Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,050
0.00 (0.00%)
Sep 11, 2024, 9:00 AM KST
-8.60%
Market Cap 153.17B
Revenue (ttm) 198.05B
Net Income (ttm) 30.04B
Shares Out 5.88M
EPS (ttm) 5,108.36
PE Ratio 5.10
Forward PE n/a
Dividend 750.00 (2.88%)
Ex-Dividend Date n/a
Volume 2,366
Open 26,050
Previous Close 26,050
Day's Range 26,000 - 26,150
52-Week Range 25,450 - 29,650
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About Daihan Pharmaceutical Co.,Ltd.

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2023, Daihan Pharmaceutical Co.,Ltd.'s revenue was 195.91 billion, an increase of 6.32% compared to the previous year's 184.27 billion. Earnings were 28.43 billion, an increase of 13.88%.

Financial Statements

News

There is no news available yet.